Showing results (151-160 of 215) with videos related to
Sort By:
Pageof 22
European Journal of Heart Failure|May 28, 2019
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real worldChris J Kapelios, Mitja Lainscak, Gianluigi Savarese, et al.European Journal of Cardiovascular Nursing|June 2, 2017
Challenges in secondary prevention after acute myocardial infarction: A call for actionMassimo F Piepoli, Ugo Corrà, Paul Dendale, et al.European Journal of Preventive Cardiology|September 8, 2016
Challenges in secondary prevention after acute myocardial infarction: A call for actionMassimo F Piepoli, Ugo Corrà, Paul Dendale, et al.European Journal of Heart Failure|October 28, 2020
Measuring physical activity with activity monitors in patients with heart failure: from literature to practice. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of CardiologyLeonie Klompstra, Martha Kyriakou, Ekaterini Lambrinou, et al.Giornale Italiano Di Cardiologia (2006)|December 23, 2024
[Mineralocorticoid receptor antagonists in heart failure with preserved/mildly reduced ejection fraction: from TOPCAT to FINEARTS-HF]Maria Denitza Tinti, Luisa De Gennaro, Emilia D'Elia, et al.European Journal of Heart Failure|April 4, 2020
Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term RegistryPatrick Rossignol, Mitja Lainscak, Maria G Crespo-Leiro, et al.Giornale Italiano Di Cardiologia (2006)|March 25, 2025
[Role of inflammation in heart failure with preserved ejection fraction: from nephro-metabolic interactions to future therapeutic implications]Emilia D'Elia, Manuela Benvenuto, Ilaria Battistoni, et al.European Journal of Preventive Cardiology|March 12, 2025
Quality of life in heart failure. The heart of the matter. A scientific statement of the Heart Failure Association and the European Association of Preventive Cardiology of the European Society of CardiologyMaurizio Volterrani, Geza Halasz, Stamatis Adamopoulos, et al.Circulation. Heart Failure|September 13, 2022
Sarcopenic Obesity Is Associated With Reduced Cardiorespiratory Fitness Compared With Nonsarcopenic Obesity in Patients With Heart Failure With Reduced Ejection FractionHayley E Billingsley, Marco Giuseppe Del Buono, Justin M Canada, et al.European Journal of Heart Failure|March 12, 2025
Quality of life in heart failure. The heart of the matter. A scientific statement of the Heart Failure Association and the European Association of Preventive Cardiology of the European Society of CardiologyMaurizio Volterrani, Geza Halasz, Stamatis Adamopoulos, et al.Pageof 22